BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh A, Chak A. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Rep (Oxf). 2015;3:303-315. [PMID: 26486568 DOI: 10.1093/gastro/gov048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, Feng X, Wang H. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Mol Carcinog 2017;56:2301-16. [PMID: 28574599 DOI: 10.1002/mc.22685] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
2 Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med 2018;10:eaao5848. [PMID: 29343623 DOI: 10.1126/scitranslmed.aao5848] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 20.3] [Reference Citation Analysis]
3 Chen L, Huang XJ, Sun Y. Endoscopic diagnosis of early esophageal carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(1): 51-58 [DOI: 10.11569/wcjd.v24.i1.51] [Reference Citation Analysis]
4 Chetwood JD, Finch PJ, Kankwatira A, Mallewa J, Gordon MA, Masamba L. Five-year single-centre experience of carcinoma of the oesophagus from Blantyre, Malawi. BMJ Open Gastroenterol. 2018;5:e000232. [PMID: 30397505 DOI: 10.1136/bmjgast-2018-000232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Levert-Mignon A, Bourke MJ, Lord SJ, Taylor AC, Wettstein AR, Edwards M, Botelho NK, Sonson R, Jayasekera C, Fisher OM, Thomas ML, Macrae F, Hussey DJ, Watson DI, Lord RV. Changes in gene expression of neo-squamous mucosa after endoscopic treatment for dysplastic Barrett's esophagus and intramucosal adenocarcinoma. United European Gastroenterol J 2017;5:13-20. [PMID: 28405317 DOI: 10.1177/2050640616650794] [Reference Citation Analysis]
6 Wanchai V, Jin J, Bircan E, Eng C, Orloff M. Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma risk. BMC Bioinformatics 2019;20:98. [PMID: 30871476 DOI: 10.1186/s12859-019-2622-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lee SW, Lien HC, Chang CS, Lin MX, Chang CH, Ko CW. Benefits of the Seattle biopsy protocol in the diagnosis of Barrett’s esophagus in a Chinese population. World J Clin Cases 2018; 6(14): 753-758 [PMID: 30510939 DOI: 10.12998/wjcc.v6.i14.753] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]